SEARCH HEALTH CONDITIONS BY ALPHABETS
Megaloblastic Anemia
Medications for Anemia, Megaloblastic
Other titles: Megaloblastic Anemia
About Anemia, Megaloblastic: Megaloblastic anemia is a blood disorder characterized by anemia, with red blood cells which are larger than normal, often resulting from a lack of folic acid or of vitamin b 12.
Drugs Used to Treat Anemia, Megaloblastic
The following set of medications are utilized at the treatment of this illness, or somehow related to.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| folic acid | Rx/OTC | A | N | Add inspection | 6.5 | ||
Generic name: folic acid blossom Brand titles: Folacin-800, FA-8 Drug category: vitamins For users: dose, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Folacin-800 | Rx/OTC | A | N | Add inspection | 0.0 | ||
Generic name: folic acid blossom Drug category: vitamins For users: dose, interactions, side effects | |||||||
| Wellcovorin | Rx | C | N | Add inspection | 0.0 | ||
Generic name: leucovorin systemic Medication course: antidotes For users: dose, interactions, side effects For specialists: AHFS DI Monograph | |||||||
| leucovorin | Rx | C | N | Add inspection | 0.0 | ||
Generic name: leucovorin systemic Brand name: Wellcovorin Medication course: antidotes For users: dose, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| FA-8 | Rx/OTC | A | N | Add inspection | 0.0 | ||
Generic name: folic acid blossom Drug category: vitamins For users: dose, interactions, side effects | |||||||
Themes under Anemia, Megaloblastic
- B12 Nutritional Deficiency (1-1 drugs)
- Folic Acid Deficiency (8 drugs)
- Folic Acid/Cyanocobalamin Deficiency (0 drugs)
- Pernicious Anemia (24 drugs in two different themes )
Legend
| Rx | Prescription Only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This medication may well not be approved by the FDA for treating the illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the embryo in the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal research studies have demonstrated a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in elderly women clearly outweigh potential benefits. |
| N | FDA has not classified this drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| Inch | Has a higher potential for abuse. Has no accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| Two | Has a higher potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may cause severe physical or psychological dependence. |
| 3 | features a potential for abuse less than those in schedules 2 and 1. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse in accordance with those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 | Has a very low potential for abuse in accordance with those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always consult your physician to ensure the information pertains to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
